Dr Cathal Kearney joined the RCSI Anatomy Department as a Senior Research Fellow in the Tissue Engineering Research Group in the Spring of 2014.
His current research focuses on the development of novel systems for on-demand delivery of bioactive factors, drugs, nanoparticles, and cells. These systems are being integrated into tissue engineering scaffolds (e.g., collagen-based scaffolds developed in TERG), as well as being tested as surface coatings on conventional implants. Adapting these systems to elicit a favorable immune response is a second key theme. Initial focus areas for application include diabetic wound healing, revascularization and bone tissue engineering.